Form EFFECT Terns Pharmaceuticals,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 7, 2026 |
| Accession Number: | 0001193125-26-205352 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CFI backs community-led research in the North with $10 million in investments
- Humsienk to Exhibit at The Intersolar Europe 2026, Unveiling the 32 kWh LiFePO4 Battery, The Real Energy Beast
- Core Aesthetics Announces Consultation-Led Care
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
